Filana Therapeutics (FLNA) FCF Margin (2010 - 2026)
Filana Therapeutics' FCF Margin was -4.13% in Q4 2013, up 71.00 percentage points from -75.12% a year earlier and up 88.78 percentage points from the prior quarter.
Powered by 
Analysis
Filana Therapeutics (FLNA) FCF Margin (2010 - 2026) Analysis & Trends
For FY2013, FCF Margin at Filana Therapeutics came in at -16.89%, up 48.95 percentage points from FY2012.
- FCF Margin shows a four-year change of +54.55 percentage points (FY2009 to FY2013).
- In earlier years, FCF Margin was -65.85% in FY2012 (-63.59 pp), -2.26% in FY2011 (-1.41 pp), -0.85% in FY2010 (+70.59 pp) and -71.44% in FY2009.
- The Q4 2013 figure marks the highest quarterly FCF Margin since Q1 2011.
- Compared with a year earlier, FCF Margin was higher in 1 of the last eight quarters, with an average year-over-year change of -32.16 percentage points.
- The best year-over-year quarter for FCF Margin over five years was Q4 2013 (a gain of 71.00 percentage points); the worst was Q1 2012 (a drop of 170.65 percentage points).
- Per Business Quant data, FLNA's FCF Margin in the three quarters before Q4 2013 was -92.90% (Q3 2013), -91.93% (Q2 2013) and -95.66% (Q1 2013).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 2.01% |
| 10 | Filana Therapeutics | 33.17 Mn | -337.67 Mn | - | -513.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -513.12% |
| Mar 31, 2026 | -1,128.01% |
| Dec 31, 2025 | -1,057.19% |
| Sep 30, 2025 | -538.47% |
| Jun 30, 2025 | -408.90% |
| Mar 31, 2025 | -896.13% |
| Dec 31, 2024 | -3,404.78% |
| Sep 30, 2024 | -699.66% |
| Jun 30, 2024 | -790.24% |
| Mar 31, 2024 | -1,076.97% |
| Dec 31, 2023 | -1,415.90% |
| Sep 30, 2023 | -1,324.29% |
| Jun 30, 2023 | -906.19% |
| Mar 31, 2023 | -663.68% |
| Dec 31, 2022 | -1,350.39% |
| Sep 30, 2022 | -2,586.10% |
| Dec 31, 2013 | -4.13% |
| Sep 30, 2013 | -92.90% |
| Jun 30, 2013 | -91.93% |
| Mar 31, 2013 | -95.66% |
API Access
Filana Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=FLNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();